Drug molecules applied to the eye normally undergo quick diluting and enzymatic degradation in the tear fluid and the diffusion barrier of the cornea and excretion by aqueous humor flow. It is extremely difficult to deliver drugs especially to the posterior eye tissues. As a result, the bioavailability of ocular drugs is very low.
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). At 4, 8, and 24 h, rabbits were sacrificed and their conjunctivas were collected in a test tube to measure the in vivo drug concentration.
One milliliter of sodium dihydrogen phosphate buffer (10 mM, pH 7.0) was added into the test tube, then the conjunctival samples were finely sectioned. After 4 ml of acetonitrile was added and mixed at 300 rpm for 10 min, the samples were centrifuged at 3000 rpm for 10 min. The supernatant (4 ml) was collected and evaporated to dryness under reduced pressure for 18 h. The residue was dissolved in 300 ml of the mobile phase and collected into the sample tube. Collected sample was centrifuged at 14000 rpm for 5 min and the supernatant was filtered. KT concentrations in the samples were determined by HPLC. There were three samples per sampling time, but those samples were triplicated and measured in view of the detection limit of the method of analysis.
In Vitro Experiment for Drug Release A modified Franz diffusion cell 4) was used for the in vitro release experiment of KT from the eye-stick. The receptor compartment was filled with 10 ml phosphate buffer (pH 7.4). The membrane filter (0.45 mm, Millipore) was placed to support the eyestick. The temperature was controlled at 37°C, and 200 ml of the receptor solution was sampled at predetermined time points. Thereafter, the same amount of fresh phosphate buffer was added to the receptor cell.
In Vitro Skin Permeation Experiment Using Hairless Mice The receptor compartment of the diffusion cell 4) was filled with 10 ml phosphate buffer (pH 7.4). The excised abdominal skin of hairless mice was used as intact skin or stripped skin, from which the stratum corneum was completely removed by tape stripping 20 times consecutively. The eye-stick of KT was then applied 10 times to the skin with a force of 2.5Ϯ0.5 N. After that, the skin was mounted on the diffusion cell quickly. The temperature was controlled at 37°C. Two hundred microliters of the receptor solution was sampled at predetermined time points. Thereafter, the same amount of fresh phosphate buffer was added to the receptor cell. This experiment was also conducted in accordance with the appropriate experimental animal guidelines.
HPLC Assay of KT The concentration of KT in the in vivo and in vitro experiments was determined under the following HPLC (Shimadzu Corporation) conditions. The assay system comprised a liquid chromatograph (LC-10AS), column oven (CTO-10A), UV-VIS detector (SPD-10A), system controller (SCL-10A), and auto injector (SIL-10A). The column was Capcell pak C18 MG S5 mm 4.5ϫ250 mm (Shiseido) and its temperature was 40°C. The measuring wavelength was 300 nm. The mobile phase was a mixture of 0.1 M tris(hydroxymethyl)aminomethane buffer (pH 9) : acetonitrileϭ30 : 70.
Simulation of Conjunctival Concentration after Eye-Stick Application Device Design Parameters: The device design parameter was calculated on the basis of drug release tests from the eye-stick. The cumulative amount of KT released per unit area was plotted against square root of time. The steady-state rate of release was obtained from the slope. The diffusion coefficient (D) of KT in the eye-stick was calculated using Eq. 1,
where Q is the cumulative amount of drug released, C 0 is the initial drug concentration in the device, and t is time.
Skin Permeation Parameters: Skin permeation data were analyzed by bilayer diffusion/partition model. 6) The cumulative amount of KT permeated per unit area was plotted against time. Lag time (t d ) was determined as the intercept between the linear portion of each curve and the time axis. The steady-state rate of penetration (dQ/dt) was then calculated from the slope. The diffusion coefficient in the stratum corneum (D SC ) or in viable skin (D VS ), the stratum corneum/viable skin partition coefficient (K SC /K VS ), and the skin surface concentration (C S ) were calculated from dQ/dt and t d .
Pharmacokinetic Parameters in Tear Fluid of Rabbits: Pharmacokinetic data in tear fluid were analyzed using one-compartment model. The distribution volume and elimination rate constant of the tear fluid of rabbits were calculated from values reported in the literature 8) (Table 1) . Simulation of Conjunctival Concentration of Rabbits: The conjunctival concentration of KT after application of eye-stick was simulated using commercially available simulation software (SKIN-CAD ® ). 9) In this simulation, an eyelid skin-tear fluid kinetics model ( Fig. 1) was used. This model consists of the device diffusion model, the skin penetration model (diffusion/partitioning model), and the tear fluid distribution/elimination model (one-compartment model). We assumed that the conjunctiva corresponded to the layer of 100 mm from the bottom of the viable skin. The device design parameters, skin permeation parameters, and tear fluid pharmacokinetic parameters were then used in SKIN-CAD ® . The thickness of the hairless mouse skin was used the value cited in the literature.
7) The thickness of the whole eyelid and the stratum corneum of the rabbit eyelid skin were measured to be 0.125 and 0.00075 cm, respectively (Table 2) .
Results and Discussion
In Vivo Conjunctival Concentration of Rabbits Figure  2 compares the KT conjunctival concentration in rabbit after eye-stick application versus eye drop administration. 10) For eye drop, the drug concentration reached the maximum value of 2.68 mg/g at 15 min and quickly decreased over Յ2 h then gradually decreased. On the other hand, the eye-stick had a lag time of about 4 h after application and a constant concentration level of drug was maintained by the end of experiment. Furthermore, the concentration was approximately equal to that at 30 min after eye drop administration. The lag time of about 4 h appearing in the first application of the eyestick may not occur with multiple applications of the stick.
The minimum effective concentration of KT may be estimated >0.028 mg/g (the value at 6 h after eye drop administration) because commercial eye drops are normally administered four times per day. The application dose of the eyestick (16 mg as KT) was much higher than that of the eye drop (0.0345 mg as KT). However, the application dose of the stick can be greatly reduced because a constant conjunctival concentration after eye-stick application is >10 fold the minimum effective concentration. This may justify the efficacy of the eye-stick as a the transdermal therapeutic system.
In Vitro Parameters The release profiles of KT from the eye-stick and the diffusion coefficient evaluated are shown in Fig. 3 and Table 3 , respectively. The weight fraction of IPM and POE in the device for this study was 45% and 5%, respectively. The concentration of KT was 1, 2, or 4% and the total volume of the device was balanced by the amount of yellow beeswax. The diffusion coefficient in the device was calculated 6.39ϫ10 Ϫ10 cm 2 /s, which was the average value of release data obtained from the eye-stick with different concentrations of KT. The skin permeation profile in vitro and the permeation parameters determined are summarized in In a precise sense, the experimental release data do not agree with Higuchi's equation; the time lag occurs in the Q vs. √t profile. This phenomenon was observed in the presence of the diffusion boundary layer. The intrinsic release rates evaluated from the method in the literature 14) agree approximately with the apparent release rate. Fig. 4 and Table 4 , respectively.
Simulation of Rabbit Conjunctival Concentration
The conjunctival concentration of KT in rabbits was simulated by a skin permeation pharmacokinetic model, SKIN-CAD ® , on the basis of the diffusion coefficient in the device, skin permeation parameters (diffusion coefficient and partition coefficient in the skin), and tear fluid pharmacokinetic parameters reported in the literature. At first, the effect of the absorption rate in the capillary layer on the conjunctival concentration was simulated as shown in Fig. 5 . In normal skin, 97-98% of the drug penetrated through the stratum corneum is taken into the microcirculation located beneath the basal layer of the epidermis.
11) As seen from this figure, the simulated profile well agreed with the in vivo data for the value of the blood absorption rate constant K b (0.07 s
Ϫ1
) at which almost 99% of the drug is absorbed into the microcirculation. In this simulation, we assumed that the blood vessels in the eyelids were located at the dermal layer; the distance to the blood vessels was about 200 mm 11) from the surface of the skin. Under in vivo conditions, however, blood vessels in the eyelids are also located at the orbicularis oculi muscle and the conjunctival layer. 12, 13) Drug penetrating through the eyelid skin may be absorbed into each blood vessel with a different absorption rate. In the in vivo experiment, eye-stick was applied ten times to the lower eyelid of rabbits. In clinical use, however, less application frequency is preferable. The effects of the application frequency of eye-stick on the conjunctival concentration are shown in Fig. 6 , where we assume a device thickness of 0.05 cm, which corresponds to ten times of application. The device thickness of 0.005 cm therefore corresponds to one application by eye-stick device.
We found little difference between ten-time application and one application.
Conclusion
The conjunctival concentration in rabbits following eyestick application is higher than that after conventional eye drop administration. Although eye drops need to be administered four times per day to maintain effective concentrations of ketotifen, eye-stick can provide a constant conjunctival concentration for an extended duration by once-daily application. The conjunctival concentration of KT in rabbits following eye-stick application could be predicted using parameters obtained from in vitro skin permeation experiments and the drug release experiments. When the absorption rate into the blood is 99%, the simulated profiles well agreed with the in vivo data. The predicted profiles indicate that application frequency have little influence on the conjunctival concentration. The eye-stick can provide a constant concentration with low application frequency, even once a day, and the present transdermal therapeutic system may be clinically effective as a new treatment device for ocular diseases. 
